Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.73 - $10.71 $2 - $42
4 Added 0.02%
19,043 $16,000
Q3 2022

Nov 10, 2022

SELL
$0.94 - $10.98 $7,483 - $87,411
-7,961 Reduced 29.49%
19,039 $23,000
Q2 2022

Aug 10, 2022

BUY
$1.16 - $1.97 $5,220 - $8,865
4,500 Added 20.0%
27,000 $36,000
Q4 2021

Feb 14, 2022

BUY
$1.8 - $5.84 $40,500 - $131,400
22,500 New
22,500 $46,000

About XORTX Therapeutics Inc.


  • Ticker XRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,389,700
  • Market Cap $17.1M
  • Description
  • XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic ki...
More about XRTX
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.